{"id":328857,"date":"2019-02-12T09:42:05","date_gmt":"2019-02-12T09:42:05","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=328857"},"modified":"2019-02-12T09:42:05","modified_gmt":"2019-02-12T09:42:05","slug":"biologics-and-biosimilars-2019-global-market-outlookresearchtrends-and-forecast-to-2024","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/biologics-and-biosimilars-2019-global-market-outlookresearchtrends-and-forecast-to-2024_328857.html","title":{"rendered":"Biologics and Biosimilars 2019 Global Market Outlook,Research,Trends and Forecast to 2024"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Biologics and Biosimilars Market”<\/div>\n<\/div>\n<\/div>\n
WiseGuyReports.Com Publish a New Market Research Report On \u2013\u201c Biologics and Biosimilars 2019 Global Market Outlook,Research,Trends and Forecast to 2024\u201d.<\/div>\n

 <\/p>\n

Biologics and Biosimilars Industry 2019<\/strong><\/a><\/p>\n

Description<\/strong>:-<\/p>\n

A biologic<\/strong> is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.<\/p>\n

Scope of the Report: 
<\/strong>Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.
Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.<\/p>\n

 <\/p>\n

Get a Sample Report<\/strong>@<\/em><\/strong>   https:\/\/www.wiseguyreports.com\/sample-request\/3739390-global-biologics-and-biosimilars-market-2019-by-manufacturers<\/a><\/p>\n

For more information or any query mail at sales@wiseguyreports.com<\/em><\/strong><\/p>\n

 <\/p>\n

The worldwide market for Biologics and Biosimilars is expected to grow at a CAGR of roughly 4.5% over the next five years, will reach 272400 million US$ in 2024, from 209400 million US$ in 2019, according to a new GIR (Global Info Research) study. 
This report focuses on the Biologics and Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.<\/p>\n

Market Segment by Manufacturers, this report covers 
<\/strong>Roche 
Amgen 
AbbVie 
Sanofi-Aventis 
Johnson & Johnson 
Pfizer 
Novo Nordisk 
Eli Lilly 
Novartis 
Merck 
3sbio 
Changchun High Tech 
CP Guojian 
Biotech 
Gelgen 
Innovent 
Dong Bao 
Ganlee<\/p>\n

Market Segment by Regions, regional analysis covers 
<\/strong>North America (United States, Canada and Mexico) 
Europe (Germany, France, UK, Russia and Italy) 
Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
South America (Brazil, Argentina, Colombia etc.) 
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)<\/p>\n

Market Segment by Type, covers 
<\/strong>Monoclonal Antibodies 
Interferon 
Erythropoietin 
Insulin 
Vaccines 
Other<\/p>\n

Market Segment by Applications, can be divided into 
<\/strong>Tumor 
Diabetes 
Cardiovascular 
Hemophilia 
Other<\/p>\n

The content of the study subjects, includes a total of 15 chapters: <\/strong><\/p>\n

Chapter 1, to describe Biologics and Biosimilars product scope, market overview, market opportunities, market driving force and market risks. 
Chapter 2, to profile the top manufacturers of Biologics and Biosimilars, with price, sales, revenue and global market share of Biologics and Biosimilars in 2017 and 2018. 
Chapter 3, the Biologics and Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.<\/p>\n

 ……..<\/p>\n

 <\/p>\n

Enquiry About Report <\/strong>@<\/em><\/strong>  https:\/\/www.wiseguyreports.com\/enquiry\/3739390-global-biologics-and-biosimilars-market-2019-by-manufacturers<\/a><\/p>\n

 <\/strong><\/p>\n

Table Of Contents – Major Key Points<\/strong><\/p>\n

1 Market Overview 
1.1 Biologics and Biosimilars Introduction 
<\/strong>1.2 Market Analysis by Type 
1.2.1 Monoclonal Antibodies 
1.2.2 Interferon 
1.2.3 Erythropoietin 
1.2.4 Insulin 
1.2.5 Vaccines 
1.2.6 Other 
1.3 Market Analysis by Applications 
1.3.1 Tumor 
1.3.2 Diabetes 
1.3.3 Cardiovascular 
1.3.4 Hemophilia 
1.3.5 Other 
1.4 Market Analysis by Regions 
1.4.1 North America (United States, Canada and Mexico) 
1.4.1.1 United States Market States and Outlook (2014-2024) 
1.4.1.2 Canada Market States and Outlook (2014-2024) 
1.4.1.3 Mexico Market States and Outlook (2014-2024) 
1.4.2 Europe (Germany, France, UK, Russia and Italy) 
1.4.2.1 Germany Market States and Outlook (2014-2024) 
1.4.2.2 France Market States and Outlook (2014-2024) 
1.4.2.3 UK Market States and Outlook (2014-2024) 
1.4.2.4 Russia Market States and Outlook (2014-2024) 
1.4.2.5 Italy Market States and Outlook (2014-2024) 
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 
1.4.3.1 China Market States and Outlook (2014-2024) 
1.4.3.2 Japan Market States and Outlook (2014-2024) 
1.4.3.3 Korea Market States and Outlook (2014-2024) 
1.4.3.4 India Market States and Outlook (2014-2024) 
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 
1.4.4 South America, Middle East and Africa 
1.4.4.1 Brazil Market States and Outlook (2014-2024) 
1.4.4.2 Egypt Market States and Outlook (2014-2024) 
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 
1.4.4.4 South Africa Market States and Outlook (2014-2024) 
1.4.4.5 Turkey Market States and Outlook (2014-2024) 
1.5 Market Dynamics 
1.5.1 Market Opportunities 
1.5.2 Market Risk 
1.5.3 Market Driving Force <\/p>\n

2 Manufacturers Profiles 
2.1 Roche 
<\/strong>2.1.1 Business Overview 
2.1.2 Biologics and Biosimilars Type and Applications 
2.1.2.1 Product A 
2.1.2.2 Product B 
2.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.2 Amgen 
2.2.1 Business Overview 
2.2.2 Biologics and Biosimilars Type and Applications 
2.2.2.1 Product A 
2.2.2.2 Product B 
2.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.3 AbbVie 
2.3.1 Business Overview 
2.3.2 Biologics and Biosimilars Type and Applications 
2.3.2.1 Product A 
2.3.2.2 Product B 
2.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.4 Sanofi-Aventis 
2.4.1 Business Overview 
2.4.2 Biologics and Biosimilars Type and Applications 
2.4.2.1 Product A 
2.4.2.2 Product B 
2.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 
2.5 Johnson & Johnson 
2.5.1 Business Overview 
2.5.2 Biologics and Biosimilars Type and Applications 
2.5.2.1 Product A 
2.5.2.2 Product B 
2.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) <\/p>\n

Continued……<\/strong><\/p>\n

Buy 1-user PDF @<\/strong>https:\/\/www.wiseguyreports.com\/checkout?currency=one_user-USD&report_id=3739390<\/a><\/p>\n

ABOUT US:<\/strong><\/p>\n

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd<\/strong>. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Biologics and Biosimilars Market” WiseGuyReports.Com Publish a New Market Research Report On \u2013\u201c Biologics and Biosimilars 2019 Global Market Outlook,Research,Trends and Forecast to 2024\u201d.   Biologics and Biosimilars Industry 2019 Description:- A biologic is a medicine made using a living … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-328857","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/328857","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=328857"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/328857\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=328857"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=328857"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=328857"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}